US Senate
Biotech

Why a US senator wants biotech leader with ‘the president’s ear’

Senator Todd Young, chair of the National Security Commission on Emerging Biotechnology, told Fierce why he's concerned about China's biopharma growth
Will Maddox Sep 24, 2026 8:00am
Eli Lilly Lilly

Eli Lilly puts up $100M for 5-target deal with China's InnoCare

Sep 24, 2026 2:39am
als

Beyond clinical endpoints: Rethinking ALS drug development through disease biology

Brought to you by Neurizon Therapeutics
Heidi Overton at HELP committee nomination hearing

Overton backs vaccines, mifepristone in confirmation hearing

Sep 24, 2026 2:32pm
federal website NIH

NIH debuts tool to help scientists navigate biomedical database

Sep 24, 2026 2:00pm
China US deals flags MA

Henlius carves out $440M T-cell engager deal with Amberstone

Sep 24, 2026 10:02am
More News

Acadia misses mark in Alzheimer’s but continues phase 3 program

Sep 24, 2026 9:46am

Roche pens $2B deal with Atavistik to discover new CVRM drugs

Sep 24, 2026 8:35am

Merck sees pivotal victory for $3B eye disease prospect

Sep 24, 2026 8:15am

Kyverna pubs 1-year miv-cel data as CAR-T peers hit safety snags

Sep 24, 2026 6:02am